Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System
DAIC
JANUARY 31, 2024
Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The
Let's personalize your content